Abstract: Recent developments in NMR hyperpolarization have enabled a wide array of new in vivo molecular imaging modalities, ranging from functional imaging of the lungs to metabolic imaging of cancer. This Concept article explores selected advances in methods for the preparation and use of hyperpolarized contrast agents, many of which are already at or near the phase of their clinical validation in patients.
Introduction
The first known attempts to split spectroscopic lines of particles using an applied magnetic field date back to Michael Faraday in 1862. [1] However, the effect was not realized until Pieter Zeeman's discovery in 1897 of field-induced broadening of sodium spectra lines. [1] The Zeeman effect of energy-level splitting of nuclear spin states in a static magnetic field is fundamental for nuclear magnetic resonance (NMR). For spin 1 = 2 nuclei, there are two such energy levels separated by DE = Àg" hB 0 , where g is the gyromagnetic ratio for the nuclear spin of a given isotope, " h = h/2p, h is Planck's constant, and B 0 is the applied static magnetic field strength. Unlike in optical and other spectroscopic methods, wherein the entire ensemble (or large fractions of the ensemble) give rise to signal formation, conventional NMR represents a special case: here, the energy level spacing is much lower than the ambient thermal energy (kT), and thus the different energy levels are nearly equally populated. Unfortunately, it is this minute difference among the populations of nuclear spin Zeeman energy levels-usually referred to as nuclear spin polarization (P) or the degree of nuclear spin alignment with the applied magnetic field-that in fact contributes to the detectable NMR signal. As governed by the Boltzmann distribution, it can be shown that P % DE/2kT or P % g" hB 0 /2kT (using the above equation) under thermal equilibrium conditions. Biomedical or in vivo applications of NMR imply temperatures of greater than 300 K, and even when high magnetic fields (up to tens of Tesla) are applied, P remains relatively low (10 À6
À4
) for biomedically relevant nuclei such as 1 H, 13 C, 15 N, 129 Xe, and others. This low value of P directly reflects the fraction of the nuclear spin ensemble contributing to the NMR signal (the rest are quite literally "radio-silent"), explaining why NMR and MRI are frequently called low-sensitivity techniques in comparison to other spectroscopic and imaging modalities.
However, in some cases P can be artificially, albeit transiently, increased well above its low thermal equilibrium level. This possibility was demonstrated at the dawn of NMR by Carver and Slichter in 1953, when they increased P of 7 Li nuclei through polarization transfer from free electrons. [2] This significant (usually orders-of-magnitude) increase in nuclear spin polarization above the thermal-equilibrium level was later called hyperpolarization (HP). The increase in polarization may be quantified by the polarization enhancement factor e, defined as the ratio of the nuclear spin polarization in HP state and that obtained at thermal equilibrium. Because the NMR signal is directly proportional to the nuclear spin polarization, the realized polarization enhancement manifests in the corresponding NMR signal and corresponding gains in detection sensitivity, which can be approximately 4-5 orders of magnitude at high field and even greater at lower fields. [3] Despite these significant gains in sensitivity achieved through hyperpolarization, the energy of RF (radiofrequency) quanta remains low, and the overall sensitivity remains relatively low as compared, for example, to optical methods.
In the more than 60 years since the first hyperpolarization demonstration, a number of hyperpolarization techniques have been developed and applied to pure elements, chemical compounds and complex mixtures with potential or realized biomedical relevance. [4] These HP compounds can be administered to patients via intravenous (IV) injection or inhalation to trace metabolism, and function in living organisms, as well as for other biomedical applications. Because the produced HP substances (also referred to as HP contrast agents) generally cannot be rehyperpolarized after their administration, the hard-won HP state will exponentially decay back to equilibrium. This decay ostensibly poses a fundamental limit on the time scale of biochemical processes that can be probed by HP contrast agents, and requires HP lifetimes that are sufficiently long (! tens of seconds) for agent manipulation after its production, administration (e.g., inhalation or injection), in vivo delivery, and observation of the metabolic/functional event. The unrecoverable nature of the HP state additionally requires highly specialized MR pulse sequences that are tailored to extract as much information as possible from the HP contrast agents. However, such efficient sequences, combined with the bright HP-endowed signal, can enable high-quality clinical 3D images of HP contrast agents to be obtained in as little as a few seconds. [5] Moreover, because the HP nuclear state is no longer endowed by the static magnetic field of the detecting MR magnet, high-field MRI scanners are no longer mandatory, and lower-cost, less-confining, low-field 3D MRI can be used instead, [6] with detection sensitivity potentially approaching or even surpassing that of high-field MRI. [7] While numerous hyperpolarization methods and strategies have been developed, this Concept article describes four methods of hyperpolarization: dissolution dynamic nuclear polarization (d-DNP), [8] spin exchange optical pumping (SEOP), [9] parahydrogen induced polarization (PHIP), [10] and signal amplification by reversible exchange (SABRE). [11] These HP methods arguably have the greatest relevance to biomedicine, given that they have each either already been tested in patients or animals models of human diseases, or have great potential and will likely be tested in vivo soon. The fundamental MR detection concepts of HP contrast are also discussed from the perspective of biomedical applications. Finally, existing and potential biomedical applications of already available and emerging HP contrast agents are discussed. While validated and emerging concepts are discussed here, the reader should additionally benefit from more comprehensive reviews on selected topics. [4, 9, 12] 
Long-Lived Spin States
Values for the in vivo spin-lattice relaxation time constant (T 1 ) for protons of water (~1.5 s) [13] and other biologically relevant and abundant molecules are usually too short to be useful for HP biomedical applications. However, T 1 values of low-g spin 1 = 2 nuclei (e.g., 13 C, 15 N, 129 Xe, 29 Si, etc.) [14] can significantly exceed 1 min. From a molecular perspective, these long times typically represent spin sites isolated from protons and paramagnetic O 2 to reduce the relaxation contribution via dipolar mechanisms. Examples include 13 C-carboxyl sites, [15] N-amines. [17] 13 C-carboxyl sites are of particular interest because of their wide distribution in major metabolic pathways such as anaerobic glycolysis, the tricarboxylic acid cycle (TCA) cycle, glutaminolysis, and many others. [4] Notably, the natural abundances of many biologically relevant isotopes such as 13 C and 15 N (1.1 and 0.36 %, respectively) are low, representing both an advantage (low background signal) and a challenge (a requirement for isotopic enrichment to boost the detection sensitivity). An alternative approach for increasing the effective lifetime of HP agents introduced relatively recently involves the use of long-lived singlet states. In this approach, the high nuclear spin order of the HP state, which otherwise would be subject to the usual relaxation mechanisms quantified by T 1 , is instead "encoded" and stored within a coupled spin pair's singlet state of the form: j S 0 i / (j abi-j bai); parahydrogen, discussed in greater detail below, contains perhaps the simplest example of a nuclear spin system in a singlet state. The decay of spin order "trapped" within a singlet state is governed by the singlet-triplet interconversion time constant (T S ), which in some circumstances can surpass T 1 values by orders of magnitude. [16, 18] Regardless of the approaches chosen for hyperpolarization preparation and storage, their applicability is often limited to a narrow range of useful HP targets, particularly when one has a given potential application in mind. This fact highlights the challenges and opportunities for innovative concepts of this rapidly emerging field of molecular imaging, where fundamental chemistry, NMR spectroscopy, and spin physics have direct and practical implications for biomedicine.
Dissolution Dynamic Nuclear Polarization (d-DNP)
d-DNP [8] relies on unpaired electrons as the source of large spin polarization in a manner similar to pioneering experiments by Carver and Slichter, [2] because g(e) % 660g( 1 H). Indeed, when electrons are subjected to sufficiently low temperatures in a static magnetic field of several Tesla, order-unity electronic polarization can be attained.
To enable the d-DNP process, a compound containing a stable free radical (e.g., the trityl radical (tris{8-carboxyl-2,2,6,6-tetra[2-(1-hydroxyethyl)]-benzo(1,2-d:4,5-d')bis(1,3)dithiole-4-yl}methyl sodium salt) [8] is first mixed with a biomolecule of interest (e.g., 1-13 C-pyruvic acid) in a solution to form a glass matrix at low temperature inside the high-field magnet (Figure 1 
a).
This glass matrix is then irradiated with a high-power microwave source at the electron resonance frequency to transfer electron spin polarization to 13 C nuclear spins in the solid state (Figure 2 b) . The exponential build-up of 13 C hyperpolarization was rather slow (~4900 s for [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C-pyruvic acid) in the original DNP hyperpolarizer by Ardenkjaer-Larsen and co-workers. [8] However, the 13 C hyperpolarization build-up time can be significantly minimized if the electron polarization is first transferred to the proton spin bath of the matrix, and then from 1 H to 13 C spins by cross-polarization in the solid state. The latter concept was demonstrated for intramolecular [19] and intermolecular [20] 1 H-to- 13 C hyperpolarization transfers, and the 13 C exponential build-up time was shortened to 810 s. The final steps of d-DNP is a rapid (on the time scale of a few seconds) dissolution and warming of the cold HP sample, and the sample transfer from the DNP hyperpolarizer magnet to the imager or NMR magnet. The resulting HP 13 C contrast agent is typically administered to a subject via IV injection within seconds after dissolution. 13 C-pyruvic acid, [8, 21] 13 C-bicarbonate, [22] 1-13 C-fumarate, [23] 5-
13
C-glutamine, [24] 15 N-choline, [17] and others. The use of long-lived singlet states was also demonstrated in a 13 C-13 C spin pair in diacetyl hyperpolarized by d-DNP.
[18b] Furthermore, recent advanced efforts of molecular deuteration enabled d-DNP and in vivo use of 13 C-choline [25] and 13 C-glucose, [26] which have significantly shorter T 1 values in their nondeuterated forms. 1-13 C-pyruvic acid, which probes glycolysis in vivo, [21] is the leading 13 C HP Figure 1 . The process of dynamic nuclear polarization (DNP) using highpower microwave irradiation of electron spins at low temperatures (few Kelvin) and high magnetic field (several Tesla). a) Glass matrix containing 13 Clabeled metabolite and radicals with unpaired electron is formed inside the high-field DNP magnet at low temperature. b) High-power microwave irradiation at the electron resonance frequency enables 13 C hyperpolarization by polarization transfer from free electrons. c) A long-lived 13 C hyperpolarized state is prepared. contrast agent, and is already being evaluated by FDA-approved prostate cancer clinical trials in men, [4, 27] work that is also fueled by the advent of a clinical-scale d-DNP hyperpolarizer with a sterile path. [28] The DNP approach is also amenable to hyperpolarized silicon nanoparticles, where experiments have exploited the high biocompatibility, surface "functionalizability", and ultralong 29 Si T 1 values (~40 min) of these systems [14] to perform HP 29 Si MRI in vivo.
[14b] It should also be pointed out that the 29 Si DNP process is conducted in the solid state as a powder, without the need for the addition of radicals (because surface defects provide the unpaired electrons needed for DNP) or glassing agents.
[14b] Finally, we should add briefly that potential clinical applications of DNP are not limited strictly to d-DNP. For example, in ex situ Overhauser DNP (ODNP), target molecules can be flowed continuously through beds containing immobilized radical species, allowing the target spins to be partially hyperpolarized with microwave application and subsequent delivery of the pure agent to the subject. In one recent example, the potential utility of ODNP-polarized water for performing perfusion MRI was demonstrated in a rat model. [29] Spin-Exchange Optical Pumping (SEOP) [32] Creation of hyperpolarized noble gases by SEOP generally requires a high-power circularly polarized laser and an optical cell (Figure 2 a) containing the target noble gas of interest, buffer gas (typically 4 He and/or N 2 ), and a small quantity of alkali metal that is partially vaporized by heating. While one could argue that the origins of the first step of SEOP-optical pumping of the alkali metal atoms (Figure 2 b)-began with Zeeman's studies of sodium vapor, [1] it was Kastler who found that the vapor of another alkali metal, rubidium, could become electronically spin-polarized when placed in a magnetic field and illuminated with resonant circularly polarized light. [33] Bouchiat, Carver, and others later showed that the electronic spin polarization of the alkali metal vapor could be transferred to nuclear spins of noble gas atoms like 3 He and 129 Xe during gas-phase collisions. [34] This second step of SEOP, termed spin exchange (Figure 2 c) , allows the nuclear spin polarization of the noble gas to ultimately approach that of the alkali metal electrons, provided that the spin-exchange rate greatly exceeds the noble gas spin-destruction rate (effectively, 1/T 1 ). Various stand-alone apparatus designs for SEOP have been developed over the years, particularly for 129 Xe; [3, 5b, 35] such so-called "Xe hyperpolarizers" are capable of generating clinically relevant quantities of HP 129 Xe with polarizations now approaching unity.
Of the NMR-active noble gas isotopes, 3 He has the greatest g value (and hence highest per atom detection sensitivity), and until recently it was the easiest to achieve the highest levels of polarization with this isotope. However, its natural abundance is extremely low, and instead is typically obtained from tritium decay; thus its future in biomedicine may be limited by the worldwide shortage of this effectively non-renewable resource. [36] The quadrupolar isotopes
Ne, 83 Kr, and 131 Xe) can also be hyperpolarized (albeit not to the same extent) but generally suffer from inherently faster T 1 relaxation; of these, 83 Kr arguably shows the greatest promise for biomedical applications, where its quadrupolar interaction may embody a complementary, surface-sensitive source of contrast compared to its spin 1 = 2 brethren. [30, 35j] Nevertheless, 129 Xe, being spin 1 = 2 , Figure 2 . Spin-exchange optical pumping. [9] a) SEOP requires an optical cell containing a noble gas, buffer gases (e.g., N 2 , as shown), and a small quantity of vaporized alkali metal (typically Rb or Cs), [47] irradiated by laser light resonant with an absorption line of the alkali metal (e.g., 794.8 nm for Rb D 1 transition). Collisions with N 2 nonradiatively quench excited Rb states, effectively suppressing deleterious Rb fluorescence that can depolarize other Rb spins.
[35a, 48] The first step of SEOP involves the absorption of photons of the same circular polarization, which conserves angular momentum by selectively depleting population from one of two Rb ground electronic (mJ = AE 1/2) states (neglecting Rb nuclear spin for simplicity). Collisions with other gasphase species tend to equalize the excited-state populations and the ground states are repopulated at effectively equal rates. However, since only one ground state is depleted by the laser, ground-state population accumulates on the other mJ state, leaving the Rb electronically spin-polarized; a weak magnetic field along the direction of laser propagation (not shown) helps to maintain the electron spin polarization. Gas-phase collisions also allow spin exchange, c) between the polarized Rb electron spins and the noble gas nuclear spins, a process mediated by Fermi-contact hyperfine interactions. Constant laser illumination of the Rb vapor therefore allows the nuclear spin polarization to accumulate over time, thereby generating the hyperpolarized noble gas. relatively inexpensive, naturally abundant, and amenable to near-unity hyperpolarization, while also possessing interesting properties (see below), will be the primary focus of the present discussion.
Xenon, while almost chemically inert, has a predilection for transiently associating with a variety of substances and surfaces, including host-guest forming "cage" compounds, nanoporous materials, membranes, and various proteins. [12b, 37] Xe also exhibits a reasonable amount of solubility in blood and other living tissues. [38] Indeed, Xe's general biomedical applications are well-documented: it is a functional anesthetic; [39] recently, it has also been implicated as a possible performanceenhancing drug as well as a potential treatment for PTSD patients. [40] Importantly here, 129 Xe also possesses an extraordinarily sensitive chemical shift, causing its resonance frequency to vary over 200 ppm simply from being physically associated with different chemical environments, enabling HP 129 Xe to be a sensitive "spin-spy" of its local surroundings. HP 129 Xe can also be a source of hyperpolarization for other systems using various polarization-transfer techniques, [41] although such approaches to date have not commonly been exploited for biomedical applications. Instead, biomedical 129 Xe MRS/MRI typically exploits xenon location-as originally demonstrated in the first biomedical application of HP Xe, void space imaging in excised mouse lungs [42] -density, motion (e.g., apparent local diffusion or exchange), chemical shift, and/or spin relaxation. One intriguing approach exploits Xe's fondness for cage compounds and its chemical shift and exchange properties in order to directly encode specific biomolecular information onto the 129 Xe signal using so-called Xe biosensors.
[43] These agents are comprised of a Xe-binding cage compound (typically a cryptophane derivative) [44] covalently tethered to some bioanalyte; if the Xe biosensor binds to a targeted protein, then the chemical shift of the bound 129 Xe changes, allowing it to be resolved from both Xe in unbound cages and Xe freely floating in solution. The potential for using such agents in vivo has been strengthened by the "hyperCEST" (hyperpolarized chemical exchange saturation transfer) approach, where the presence of even a small amount of Xe-occupied cages bound to their biomolecular targets can be encoded onto the easierto-detect signal from Xe in the bulk environment. As another example, Branca and co-workers demonstrated the promise of a different but clever approach to achieving molecular imaging using HP gases: [45] with the goal of visualizing lung metastases, cancer cells are first targeted by superparamagnetic nanoparticles (SPIONs) surface-functionalized with cancer-binding molecules, and then the lung space is imaged with HP noble gases (here, Xe detection modality, HP Xe can be delivered to the subject by inhalation [12b, c, f, 30] or by the administration of Xe-saturated biologically tolerable solutions.
[46]
ParaHydrogen Induced Polarization (PHIP)
The PHIP method of hyperpolarization relies on fast chemical reactions that enable pairwise addition of p-H 2 across unsaturated chemical bonds, typically C=C or C C bonds adjacent to 13 C carboxyl or 15 N [49] nuclei. Bowers and Weitekamp demonstrated that the nuclear spin singlet state of parahydrogen molecules can be converted into observable magnetization arising from the magnetically inequivalent positions at the site of hydrogenation with p-H 2 [50] (Figure 3 c) . The chemical reaction of pairwise p-H 2 addition should be performed faster than the nuclear spin relaxation of the nascent protons. Goldman, Spiess, Bargon and Golman later demonstrated that the nascent proton hyperpolarization can be transferred to carboxyl 13 C nuclei to yield HP 13 C contrast agents in seconds using either RF-based or field-cycling hyperpolarization-transfer approaches, respectively (Figure 3 c) .
[51] The speed of the PHIP method is one of its main advantages, while the requirement for an unsaturated molecular PHIP precursor with appropriate asymmetry is a significant limitation for biological applications. Moreover, RF-based PHIP polarization transfer (Figure 3 c) benefits from deuteration of the molecular precursor and also further increases the design complexity for the molecular PHIP precursor. [52] Nevertheless, a number of potentially useful biomolecules were successfully hyperpolarized using PHIP, including 1-13 C-succinic acid, [53] 1-13 C-phospholactate, [52, 54] tetrafluoropropyl 1-13 C-propionate, [55] 15
N-propargylglycine, [49] 13 C-glucose derivative, [56] and others. Despite the synthetic challenges, new concepts of using ÀOH protection in ÀC=CÀ OÀR motifs have significantly expanded the reach of molecular targets for PHIP, [54, 57] because the protecting group can be removed after PHIP either metabolically [52, 54, 58] or synthetically. [57] The PHIP hydrogenation procedure has often been conducted conventionally with homogeneous Rh I -based catalysts (e.g., Wilkinson's catalyst), [59] which more recently have been replaced by water-soluble bisphosphine Rh I catalysts, enabling biomedical use in vivo. [51a, 53a, 55] However, Koptyug and co-workers [60] demonstrated that heterogeneous catalysts including supported metal nanoparticles of Rh and other metals, [12e] which despite ostensibly relying on predominantly non-molecular mechanisms of hydrogenation, can in fact yield a significant fraction of the hydrogenated product by effectively "pairwise" addition of p-H 2 , resulting in HP product. The "HET-PHIP" concept was demonstrated in the creation of HP propane and other gases, [12e] substances which in principle can be used directly in biomedical applications like gas MRI (similar to HP noble gases discussed above). HP propane with P H > 0.01 has already been demonstrated to be useful for high-resolution 3D MRI in phantoms. [61] These new supported metal catalysts can also be applied for heterogeneous PHIP at the liquid-solid interface, [12e] and may enable the production of pure aqueous HP contrast agents-agents that have already been previously prepared by homogeneous catalysis and shown to be promising targets for biomedical applications. [52, 53b, c, 54, 55, 58] The potential realization of this emerging concept would additionally allow recycling the catalyst, making PHIP a truly low-cost, high-throughput, sustainable, and scalable HP technique.
As stated above, PHIP relies on the pure spin order of the singlet state of p-H 2 ; [50] but first, the spin order must be generated. H 2 molecules can exist in both para-(spin-0) and ortho- [63] resulting in a statistical 3:1 (ortho/para) spin isomer distribution at normal "high-temperature" conditions. However, because the p-H 2 singlet corresponds to the lower-energy state of these two spin isomers, "normal" H 2 gas can be converted to preferentially favor the p-H 2 spin isomer by cooling the gas to cryogenic temperatures (Figure 3 b) . The process of para,ortho interconversion is normally very slow (on the time scale of months if not longer) [64] but can be significantly accelerated through the use of a catalyst in the p-H 2 -generating equipment (Figure 3 a) . [65] When H 2 gas passes through the cold catalyst-filled chamber (Figure 3 a) , it is rapidly converted to the local equilibrium p-H 2 fraction determined by the low temperature of the cryogenically cooled chamber (Figure 3 b) . The exiting p-H 2 is then warmed to room temperature (RT), and is typically stored in an aluminum tank for PHIP and SABRE applications. While the enriched p-H 2 is thermodynamically less favorable at RT, it is effectively kinetically trapped in the para-state, and can be stored for weeks or months in the absence of paramagnetic impurities such as O 2 . It should also be noted that p-H 2 is NMR-invisible, because its net spin is zero; perhaps ironically, it is the o-H 2 spin isomer that provides the NMR signal for H 2 gas. This property is conveniently used to quantify the percentage of p-H 2 enrichment using conventional high-resolution NMR. [64, 66] Signal Amplification by Reversible Exchange (SABRE) SABRE [11, 62] is a relatively new PHIP-based hyperpolarization technique pioneered by Duckett and co-workers in 2009. However, while SABRE relies on p-H 2 exchange on a metal complex, it differs from traditional PHIP in that the p-H 2 does not chemically react with the substrate molecule to be hyperpolarized. Indeed, in SABRE the substrate also exchanges rapidly between the bulk solution environment and the organometallic catalyst complex, allowing spin order to be spontaneously transferred from exchangeable ("para-")hydride to the substrate molecule at low [62] and high [67] magnetic fields ( Figure 3 d; believed to be mediated by scalar couplings, applied fields, and dipolar crossrelaxation). The exchangeable organometallic catalyst is the key element of SABRE hyperpolarization method, [68] and the most effective iridium N-heterocyclic carbene complexes [69] have been used to achieve substrate hyperpolarization with P as high as approximately 8 %. This method, previously demonstrated on pyridine and nicotinamide, has already been efficiently expanded to other biologically relevant molecules such as the tuberculosis drugs pyrazinamide and isoniazid. [70] While the vast majority of SABRE studies are carried out in organic solvents, the first efforts to achieve SABRE hyperpolarization in aqueous/organic [71] and purely aqueous media [72] are promising, particularly given the fact that SABRE-barely five years old-is still very much in its infancy. Moreover, the first demonstration of heterogeneous SABRE was recently reported, [73] ultimately paving the way to applications where the SABRE catalysts, consisting of metal complexes covalently tethered to solid supports, may be recycled, and pure solutions of HP contrast agent may be produced. Once combined with SABRE in aqueous media, this method may in fact embody a cheap, efficient, and scalable approach to quickly produce large quantities of pure HP contrast agents on demand. If realized, this would provide a clear strength of the SABRE approach.
Detection of Hyperpolarized Contrast Media
Because HP magnetization for a given "batch" of HP agent is transient and cannot be regenerated in biomedical applications, it irrevocably decays to its equilibrium value, typically several orders of magnitude weaker than that embodied by Figure 3 . a, b) Conversion of "normal" H 2 gas (75 % ortho-and 25 % para-isomers) into parahydrogen (p-H 2 ). a) Schematic of a p-H 2 generator, where the entering room temperature ("normal") H 2 gas is cryo-cooled to 77 K and catalytically converted under local equilibrium to a mixture of spin isomers that preferentially favors p-H 2 . Because the catalyst is confined to a cryogenically cooled chamber of the polarizer, once the p-H 2 leaves the chamber it is kinetically trapped in the para-state. b) Temperature dependence of the equilibrium p-H 2 percentage. Liquid N 2 temperature (77 K) allows for preparation of 50 % p-H 2 , whereas temperatures below 20 K enable production of > 97 % p-H 2 fraction. c) The process of parahydrogen induced polarization (PHIP). The pairwise addition of a p-H 2 molecule to a molecular precursor, which is typically accomplished across a C=C or C C bond adjacent to a 13 C nucleus using a hetero-or homogeneous catalyst. The resulting chemically "unlocked" nuclear spin hyperpolarization of the nascent, magnetically inequivalent protons can be used as-is, or transferred to the typically longerlived (greater T 1 ) 13 C site using either an RF pulse sequence or a field-cycling method. d) The process of signal amplification by reversible exchange (SABRE). A metal complex [M] enables p-H 2 and a substrate to be transiently co-located under conditions of dynamic exchange, resulting in spontaneous polarization transfer [11, 62] from p-H 2 to the substrate. the HP state; moreover, each acquisition RF pulse "uses up" some of the hard-won HP magnetization. On the other hand, the bright signal provided by the HP agent obviates the need for built-in delays that may otherwise be required to allow equilibrium spin polarization to refresh after each acquisition. As a result of these facts, most conventional NMR and MRI pulse sequences cannot be readily used for HP media without at least some modification. Importantly, an additional source of signal decay for a HP contrast agent in living tissues is its metabolism. For example, in vivo injection of HP 1-13 C-pyruvate leads to its rapid enzymatic conversion to HP 1-13 C-lactate and 1-13 C-alanine (Figure 4 a) . [21a] Such processes highlight a clear strength of HP MRI, as both contrast agent uptake and its metabolism can be detected and quantified, thereby providing an additional layer of molecular information. However, the biochemical change of the signal source also represents a challenge for MRI pulse sequence development, because the simultaneous presence of HP 13 C signals from multiple species complicates image encoding and reconstruction. This problem is resolved through the addition of the spectroscopic dimension to the spatial dimensions of MRI pulse sequences through an established method called chemical shift imaging (CSI), which enables detection of spectra from individual voxels [21a, 74] that can later be used to reconstruct metabolic maps of HP species, that is, originally injected HP contrast agent (pyruvate) and its products (lactate and alanine), as shown in Figure 4 a. Furthermore, more advanced pulse sequences with frequencyselective RF pulses can be designed to sample only metabolites (the products of interest) rather than the original contrast agent, which also serves to minimize polarization losses due to RF excitation. [75] HP RF pulse sequences rarely use full (908 flip-angle) or nearly full NMR signal excitation (with an exception of statestate free precession (ssfp) sequences, where gradient refocusing is utilized), [66, 75c, 76] because the HP magnetization is finite and nonrenewable; the detected magnetization is proportional to the sine of the applied RF pulse angle, whereas the residual magnetization is proportional to the cosine of the applied RF pulse angle (Figure 4 c) . As a result, the use of low-tippingangle excitation RF pulses (i.e., just a few degrees) is highly advantageous for HP MRI sequences, because doing so retains most of the available HP magnetization for subsequent acquisitions (allowing the HP but finite magnetization to be "metered out" as efficiently as possible). Moreover, unlike conventional MR, where a recovery time interval in the pulse sequence is needed to re-establish the equilibrium nuclear spin polarization, HP MR pulse sequences no longer need this recovery interval because HP magnetization is created outside of, and not by, the imaging magnet (Figure 4 d) . Thus, a HP pulse sequence train needs only to contain the encoding and detect- ing elements, thereby providing significant imaging acceleration, with repetition times on the order of a few ms, and entire 3D scanning times on the order of seconds.
[5b] However, even with small RF tipping angles, if the excitation RF pulse width is kept fixed, the decaying HP magnetization will a yield progressively reduced MR signal during the pulse sequence train due to the previous pulsing, as well as T 1 and other polarization losses. This shortcoming can be mitigated through the use of pulse sequences with progressively increasing RF pulse tipping-angle to maintain (ideally) the same induced MR signal throughout the progression of the sequence train (Figure 4 d) .
Many HP imaging applications require fast scanning speed. For example, performing a 3D MRI lung scan on a single patient breath hold restricts the scanning duration to just a few seconds. Imaging scanning speed can be additionally significantly accelerated through the use of compressed sensing, [75a, 76] where only a fraction of k-space is sampled, which can lead to a corresponding several-fold reduction in total scan time.
Biomedical Translation
To date, a number of HP contrast agents have been developed and tested in animal models of human diseases, human subjects, or both, including: HP 1-13 C-pyruvate, reporting on upregulated glycolysis in cancers; [21b, 77] [23] reporting on TCA cycle metabolism; HP 5-13 C-glutamine, reporting on elevated glutaminolysis in cancer; HP 29 Si nanoparticles [14] and others, with more on the way. However, clinical biomedical translation of the fundamental advances in the chemistry and physics of HP MR requires several components: 1) a clinical-scale hyperpolarizer capable of producing HP agent doses suitable (quantity, purity, sterility, etc.) for administration to patients; 2) regulatory approvals from government agencies and local institutions; and 3) an MRI scanner capable of multinuclear ( 1 H as well as 13 C, 129 Xe, etc.) detecting capabilities, including specialized RF coils, custom RF pulse sequences, etc.; and of course 4) trained, dedicated personnel capable of navigating/operating 1-3 above. Despite these requirements and challenges, a number of clinical or preclinical human trials are underway, or already completed, with HP 129 Xe (produced via SEOP) and HP 13 C (produced by d-DNP). Examples of clinical research HP MRI are provided in Figure 5 . Figure 5 a shows two selected slices of 3D functional pulmonary ventilation imaging scan using HP 129 Xe. HP 129 Xe was inhaled by a healthy volunteer, and the entire 3D MRI exam was conducted in less than five seconds on a single breath hold.
[5b, 35e] Bright signals are obtained from the void spaces of the lungs, as the enormous signal provided by the HP 129 Xe more than outweighs the low-spin density of the gas phase. Moreover, the background signal from surrounding tissues is non-existent due to the virtual absence of Xe naturally occurring in the body. The potential utility of two other features of 129 Xe-its highly sensitive chemical shift and its tendency to be rapidly absorbed by living tissues-is demonstrated in Figure [79] Figure 5 c shows examples taken from a magnetic resonance spectroscopic imaging (MRSI) study using intravenous injection of HP 1-13 C-pyruvate. [27] The injected HP 1-13 C-pyruvate is rapidly converted to HP 1-13 C-lactate by LDH (Figure 4 a) , and the ratio 1-13 C-lactate/ 1-13 C-pyruvate [77b] (measured as the intensity ratio of HP signals of HP 1-13 C-lactate and 1-13 C-pyruvate in the spectroscopic domain of MRSI; see Figure 4 a) serves as a metabolic imaging biomarker of prostate cancer. This ratio of HP signals is presented as a false-color overlay image co-registered with a conventional T 2 -weighted MRI of prostate (greyscale), and is shown for three prostate cancer subjects. Note that the tumors are very difficult to detect on conventional proton MRI images (top row of Figure 5 b), while the metabolic molecular imaging offers additional contrast mechanism that can delineate diseased tissues from healthy ones by "lighting up" regions with potentially pathological metabolism.
Conclusion
HP contrast agents with biomedical relevance can be now prepared by several hyperpolarization techniques, including: d-DNP, SEOP, PHIP, and SABRE. These techniques significantly increase nuclear spin polarization and hence MR sensitivity by orders of magnitude, permitting new biomedical applications including functional and metabolic molecular imaging. HP contrast agents hold great promise to enable a broad range of new imaging biomarkers for molecular imaging of deadly diseases such as cancer, COPD, emphysema, and others. Compared to positron emission tomography (PET), which is the leading molecular imaging modality, HP MRI offers advantages of: 1) being nonradioactive and nonionizing, and 2) potentially providing more metabolic information rather than only reporting on contrast-agent uptake, and 3) very short (few seconds) imaging scan with possibility of multiple same-day examinations. [80] Furthermore, some hyperpolarization techniques (PHIP and SABRE) and detection methods (low-field MRI) potentially offer additional advantages of speed, throughput and cost. While the seeds of most hyperpolarization techniques were planted decades ago, most have matured for biomedical applications only during the last decade. Indeed, there is a tremendous room for innovation in fundamental physics, chemistry, biochemistry, and engineering that could significantly improve or even revolutionize this emerging area of molecular imaging. Figure 5 . Examples of biomedical use of hyperpolarized contrast agents in human subjects for pulmonary functional imaging,
[5b] spectroscopy and imaging of brain uptake of 129 Xe, [79] and molecular imaging of prostate cancer.
[27] a) Two slices selected from a 3D
129
Xe gradient echo (GRE) chest image from a healthy human volunteer following inhalation of HP Xe from an 800 cc Tedlar bag containing a mixture of HP Xe (86 % enriched 129 Xe/N 2 , 65:35 by volume). Subject performed two respiration cycles (total lung capacity to functional residual capacity), inhaled from bag, and then took a small gulp of air (to help push HP Xe out of the trachea); TE/TR, 1.12/ 11 ms (specific absorption rate-limited); tipping angle, 68; 80 80 14; acquisition time, 4.5 s; FOV, 320 320 196 mm 3 ; 2214 mm 3 digital resolution after zero-filling (SNR~8-15).
[ [79] c) Representative examples of 3D single-time-point magnetic resonance spectroscopic imaging (MRSI) data of three prostate cancer subjects after IV injection of HP 1-13 C-pyruvate. [27] The axial T 2 -weighted images and false-color overlays of hyperpolarized 1-13 C-lactate/1-13 C-pyruvate ratio are from the three patients labeled as B, C, and D. All three of the patients had biopsy-proven Gleason grade 3 + 3 prostate cancer and received the highest dose of hyperpolarized 1-13 C-pyruvate (0.43 mL kg
À1
). Patients B, C, and D had current PSAs of 5.1, 9.8, and 1.9 ng mL À1 , respectively. The SNR and metabolite ratios in the regions highlighted in color on the image overlays are given in Table 2 of reference [27] . Reprinted with permission from AAAS. 
